3rd Quarter - Amendment

FARRAGUT PARTNERS LLP for GILEAD SCIENCES INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$80,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 18, 2019 $80,000 Replaced
3rd Quarter - Amendment (this page) Oct 18, 2019 $80,000 Replaced
3rd Quarter - Amendment Oct 21, 2019 $80,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Coverage and reimbursement policy for HCV and HIV portfolios. Issues pertaining to the 340B drug discount program.Issues pertaining to the five protected classes. Drug pricing legislation- part D redesign.

LobbyistCovered position, as disclosed
JODY SHINTARO GALE —
JEFF MACKINNON LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER Prof Staff on E&C Cmte LA Rep Whitfield and Intern Devin Nunes
KRISTEN O'NEILL Health Policy Advisory, LA, Staff Assistant Gene Greene (D-TX) Staff Assistant GK Butterfield (D-NC)
J DANIEL WALSH LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
SARAH WALTER Former Legislative Director/Chief Counsel, Sen. John Breaux
EDWARD WHITFIELD U.S. Representative (21 yrs.)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.